S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
TSLA   564.82 (-1.29%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
TSLA   564.82 (-1.29%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
TSLA   564.82 (-1.29%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
TSLA   564.82 (-1.29%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
Log in

NYSE:SNN - Smith & Nephew Stock Price, Forecast & News

$50.57
+1.17 (+2.37 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
$50.15
Now: $50.57
$50.69
50-Day Range
$44.08
MA: $47.62
$49.82
52-Week Range
$37.30
Now: $50.57
$50.69
Volume876,546 shs
Average Volume469,947 shs
Market Capitalization$22.12 billion
P/E Ratio25.03
Dividend Yield1.13%
Beta0.26
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-20-7401-7646

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.90 billion
Cash Flow$3.05 per share
Book Value$11.14 per share

Profitability

Miscellaneous

Employees16,377
Market Cap$22.12 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.


Smith & Nephew (NYSE:SNN) Frequently Asked Questions

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a -- dividend on Monday, September 23rd. Stockholders of record on Friday, October 4th will be paid a dividend of $0.288 per share on Wednesday, October 30th. This represents a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, October 3rd. View Smith & Nephew's Dividend History.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) announced its quarterly earnings data on Monday, November, 17th. The medical equipment provider reported $0.98 EPS for the quarter, topping the Zacks' consensus estimate of $0.39 by $0.59. View Smith & Nephew's Earnings History.

When is Smith & Nephew's next earnings date?

Smith & Nephew is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Smith & Nephew.

What price target have analysts set for SNN?

5 brokerages have issued twelve-month price objectives for Smith & Nephew's stock. Their forecasts range from $6.00 to $6.00. On average, they expect Smith & Nephew's stock price to reach $6.00 in the next twelve months. This suggests that the stock has a possible downside of 88.1%. View Analyst Price Targets for Smith & Nephew.

What is the consensus analysts' recommendation for Smith & Nephew?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Smith & Nephew.

Has Smith & Nephew been receiving favorable news coverage?

News stories about SNN stock have trended somewhat positive recently, InfoTrie reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Smith & Nephew earned a news sentiment score of 1.3 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Smith & Nephew.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a increase in short interest in December. As of December 13th, there was short interest totalling 904,300 shares, an increase of 11.0% from the November 28th total of 814,700 shares. Based on an average trading volume of 721,500 shares, the short-interest ratio is currently 1.3 days. Approximately 0.2% of the shares of the stock are short sold. View Smith & Nephew's Current Options Chain.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Enterprise Products Partners (EPD), Pfizer (PFE), AT&T (T), Alexion Pharmaceuticals (ALXN) and Broadcom (AVGO).

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the folowing people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by many different of institutional and retail investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.04%), Henry James International Management Inc. (0.04%), Boston Trust Walden Corp (0.02%), Eqis Capital Management Inc. (0.01%), FNY Investment Advisers LLC (0.01%) and Reilly Financial Advisors LLC (0.01%).

Which major investors are selling Smith & Nephew stock?

SNN stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Boston Trust Walden Corp, Eqis Capital Management Inc., United Services Automobile Association, Telemus Capital LLC, Reilly Financial Advisors LLC, Henry James International Management Inc. and Janney Montgomery Scott LLC.

Which major investors are buying Smith & Nephew stock?

SNN stock was purchased by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, Raymond James Trust N.A., Park National Corp OH, IFP Advisors Inc, Advisor Partners LLC, Harel Insurance Investments & Financial Services Ltd. and Huntington National Bank.

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $50.57.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of $22.12 billion and generates $4.90 billion in revenue each year. The medical equipment provider earns $663 million in net income (profit) each year or $2.02 on an earnings per share basis. Smith & Nephew employs 16,377 workers across the globe.View Additional Information About Smith & Nephew.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is http://www.smith-nephew.com/.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 ADAM STREET, LONDON X0, WC2N 6LA. The medical equipment provider can be reached via phone at 44-20-7401-7646 or via email at [email protected]


MarketBeat Community Rating for Smith & Nephew (NYSE SNN)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  370 (Vote Outperform)
Underperform Votes:  625 (Vote Underperform)
Total Votes:  995
MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew and other stocks. Vote "Outperform" if you believe SNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel